Addyi 100 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FE919
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,324
Award facts
- Contract value 100% obligated
- $14,323.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded Amerisourcebergen Drug Corp a delivery order valued at $14,323.79 for ADDYI (flibanserins) 100 mg tablets in quantities of 30 units. This firm fixed-price, non-competitive delivery order was issued on January 21, 2026, with an ultimate completion date of January 22, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order was issued under Amerisourcebergen Drug Corp's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle designed to support military healthcare programs globally through December 2031.
This task order demonstrates the critical role that pharmaceutical distributors play in supporting federal medical supply chains, particularly for military and veteran healthcare systems. ADDYI is a prescription medication approved for premenopausal women with hypoactive sexual desire disorder, and its inclusion in DLA procurements reflects the breadth of pharmaceutical needs across military medical treatment facilities. As one of the nation's largest pharmaceutical distributors, Cencora, Inc. (operating as Amerisourcebergen) leverages its established indefinite delivery contract to efficiently fulfill government requirements for diverse medications across multiple therapeutic domains, ensuring the Defense Health Agency and other federal healthcare systems maintain adequate pharmaceutical inventories.
Quick answers
Who was awarded contract SPE2DR26FE919?
SPE2DR26FE919 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FE919 worth?
The government has obligated $14,324 on SPE2DR26FE919.
Is contract SPE2DR26FE919 an order under another contract?
Yes. SPE2DR26FE919 is a delivery order under SPE2DR25D1103, an indefinite delivery contract.
Was contract SPE2DR26FE919 competed?
The extent of competition for SPE2DR26FE919 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award